Kenth Gustafsson

Title: Kenth Gustafsson: Innovator in T Cell Technology

Introduction

Kenth Gustafsson is a notable inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the development of T cell technologies. His innovative work has the potential to advance therapeutic strategies in cancer treatment.

Latest Patents

Gustafsson holds a patent for a T cell that expresses a gamma-delta T cell receptor (TCR) and a chimeric antigen receptor (CAR). This invention provides a T cell that includes an antigen binding domain, a transmembrane domain, and a co-stimulatory intracellular signaling domain. The intracellular signaling domain is designed to provide a co-stimulatory signal to the T cell following the binding of antigen to the antigen binding domain. This patent represents a significant advancement in the field of cellular therapies.

Career Highlights

Kenth Gustafsson is associated with UCL Business Plc, where he continues to work on innovative projects that aim to enhance the efficacy of T cell therapies. His expertise in the field has positioned him as a key figure in the development of new immunotherapeutic approaches.

Collaborations

Gustafsson collaborates with notable colleagues, including John Anderson and Jonathan Fisher. Their combined efforts contribute to the advancement of research and development in T cell technology.

Conclusion

Kenth Gustafsson's work in T cell technology exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic options in the fight against cancer.